Exclusive Summary

• Exhausted patents eliminate all IP barriers, enabling secure, fast-track market entry and commercialization for overseas distributors.
• Perfectly matched with the surging global demand driven by an aging demographic suffering from BPH and hypertension, ensuring immense volume potential.
• Delivers a unique 'dual-action' clinical advantage that treats both high blood pressure and urinary symptoms concurrently, highly favored for elderly male comorbidities.
• Capitalizes on China's integrated API-to-FDF supply chain to provide superior cost-effectiveness, securing highly lucrative margins and bidding superiority.
• Backed by rigorous GMP compliance and comprehensive CTD dossiers, seamlessly empowering local partners to expedite regulatory filings and approvals.